CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
Journal
Oncology
Journal Volume
96
Journal Issue
3
Pages
156
Date Issued
2019
Author(s)
Abstract
We aimed to study the prognostic role of CpG island methylator phenotype (CIMP) in patients with different stages of colorectal cancer (CRC).
Subjects
CpG island methylator phenotype; Overall survival; Stage IV colorectal cancer
SDGs
Other Subjects
B Raf kinase; BRAF protein, human; KRAS protein, human; protein p21; adult; aged; Article; BRAF V600E gene; cancer mortality; cancer patient; cancer prognosis; cancer staging; cancer survival; clinical feature; colorectal cancer; controlled study; CpG island; CpG island methylator phenotype; DNA methylation; exon; female; gene mutation; hazard ratio; human; major clinical study; male; microsatellite instability; multivariate analysis; oncogene K ras; overall survival; phenotype; prediction; priority journal; very elderly; cancer staging; colorectal tumor; genetics; middle aged; mortality; mutation; pathology; prognosis; survival rate; Aged; Colorectal Neoplasms; CpG Islands; DNA Methylation; Female; Humans; Male; Microsatellite Instability; Middle Aged; Mutation; Neoplasm Staging; Prognosis; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Survival Rate
Publisher
KARGER
Type
journal article